Kleanthis Xanthopoulos
businessMale0.0Global Dominance: 0.00%
Kleanthis Xanthopoulos is the co-founder and CEO of Shoreline Biosciences and has been influential in the field of cell therapies, discussing innovative approaches to treating diseases such as cancer through genetically modified cells.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Kleanthis Xanthopoulos delivered a notable speech on the future of cell therapies.
Χαρτογραφώντας την ιατρική επανάσταση | Η ΚΑΘΗΜΕΡΙΝΗKathimerini·
Greece· 2025-05-24
Greece· 2025-05-24
